Live webinar: 18:00-19:30 on Thursday, 19 October 2023
Pre-recorded material: available from Thursday, 28 September 2023
Venue: Virtual Zoom webinar
This virtual event is organised by the BSH Lymphoma Special Interest Group and is aimed at consultants, SpRs, CNS, nurses, trial practitioners and pharmacists. Participants will gain a greater understanding of the management of lymphoma, focusing on contentious issues which provoke discussion on the MDT.
The event will consist of four pre-recorded video presentations and a live webinar. Videos will be available to registered delegates to access and view in their own time prior to the live webinar. The webinar, lasting 90 minutes, will feature Q&A session and summary of key messages on each of the topics with audience interaction. It will be hosted by session chairs with the panel including speakers on all four topics.
Pre-recorded presentations and topics (available from Thursday 28 September 2023):
- Marginal Zone lymphomas management - 1st line and relapse: Renata Walewska and Kim Linton Focus on gastric MALT and SMZL.
- 1st line MCL management in 2023: Toby Eyre and Rory McCulloch.
- Relapsed refractory Hodgkin lymphoma, management - chemo vs novel agents and combinations: Graham Collins and Cathy Burton.
- Relapsed refractory DLBCL treatment in 2023 - focus on CAR-T and bispecifics: Andrea Kuhnl and Will Townsend.
Live webinar: 18:00-19:30 on Thursday, 19 October 2023
Chairs: Sridhar Chaganti and Cathy Burton
- Key messages, questions and answers
For further information please contact [email protected].
Event Availability
- Consultants
- £0.00 (BSH members)
- £20.00 (non members)
- October 19th 2023
- Trainees
- £0.00 (BSH members)
- £10.00 (non members)
- October 19th 2023
To register for this event, please log in or register for the website.
If you are a BSH Member, this will allow you to claim a discount on most educational events: read more about the benefits of Membership.
